- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03148171
Project WERK (Wellness Encouragement Respect Kinship) (WERK)
May 8, 2024 updated by: University of Chicago
Project WERK (Wellness Encouragement Respect Kinship): Network Support to Engage and Retain Younger Black MSM in PrEP Care
The Project WERK intervention is a brief, theory based and culturally sensitive intervention designed to capitalize on organic yet underutilized social support networks in the lives of young black men who have sex with men (YBMSM).
The intervention has been developed with input from clients and their support network members, case managers, social workers, primary care providers.
The goal of the intervention is to improve retention in PrEP care for young Black MSM.
Study Overview
Detailed Description
Project WERK will recruit, consent and randomize 160 men, with 80 men randomized to each arm of the study.
Men randomized to the control condition will receive standard PrEP care at each clinical site.
Men randomized to the experimental condition will receive standard PrEP care and also will be asked to recruit a supportive contact from their social network.
The support contact will then be engaged in a brief intervention designed to support their friend/family member around PrEP Care.
Men and support contacts in the WERK intervention also will receive booster sessions via telephone and text.
All participants will complete surveys at baseline and at three and twelve months post intervention.
Study Type
Interventional
Enrollment (Actual)
290
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60615
- Chicago Center for HIV Elimination
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 35 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion criteria
Index subjects:
- Self-identify as African American/Black;
- Assigned male sex at birth;
- Any same gender anal or oral sex in the past 2 years;
- English speaking;
- Have at least one support contact in their network;
- Own a cell phone not shared with other persons;
- Between the ages of 18-35 years old; and
- Have had fewer than 3 PrEP clinical visits in the past 12 months.
Support Contact:
- Index participant has agreed to including the support contact
- Willing to attend face to face and telephone mini-booster sessions;
- 18 years of age or older;
- English speaking; and
- Owns a cell phone that is not shared with other persons.
Exclusion Criteria
Index Subject:
- Unable to provide informed consent;
- Plan to move out of the area within the next 12 months;
- Are not willing to attend intervention sessions; or
- Not willing to return for assessments.
For index participants without a support contact, we will refer them to an appropriate support group for PrEP.
Support Contact:
- Romantic partner of index participant;
- Unable to provide informed consent;
- Plan to move out of the area within the next 12 months;
- Are not willing to attend intervention sessions; or
- Not willing to return for assessments.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Routine PrEP Care
Routine PrEP Care at each clinical site.
|
|
|
Active Comparator: WERK Supportive Contact
Support contact will provide emotional support and practical support in order to help their friend/family member to stay engaged in PrEP Care.
|
Provide emotional support and practical support.
Support friend/family by helping him to stay engaged in PrEP Care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Retention in PrEP Care
Time Frame: 12-month
|
Completing scheduled PrEP visits as determined by Electronic Medical Record (EMR) data
|
12-month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
HIV testing and STI testing
Time Frame: 12 months
|
HIV serostatus and STI testing as determined by EMR data
|
12 months
|
|
Closeness and social support
Time Frame: 12 months
|
Closeness and social support measures based on self-report
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Alida Bouris, PhD, University of Chicago
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 9, 2017
Primary Completion (Actual)
June 15, 2020
Study Completion (Actual)
June 15, 2020
Study Registration Dates
First Submitted
May 8, 2017
First Submitted That Met QC Criteria
May 9, 2017
First Posted (Actual)
May 10, 2017
Study Record Updates
Last Update Posted (Actual)
May 10, 2024
Last Update Submitted That Met QC Criteria
May 8, 2024
Last Verified
May 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- IRB17-0152
- R34MH111392 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV Prevention
-
Duke UniversityGilead SciencesRecruitingHIV Prevention | HIV Pre-exposure Prophylaxis | HIV Prevention Program | HIV Prevention and Care | HIV Pre-exposure Prophylaxis UseUnited States
-
University of California, Los AngelesRecruitingHIV PreventionUnited States
-
University of Alabama at BirminghamNational Institute of Mental Health (NIMH)RecruitingPrEP | HIV | HIV Prevention | PrEP UptakeUnited States
-
Institute of HIV Research and Innovation Foundation...National Institutes of Health (NIH)RecruitingHIV Prevention | PrEP Adherence | HIV Related StigmaThailand
-
Medstar Health Research InstituteNational Institute of Mental Health (NIMH)CompletedHIV Prevention ProgramUnited States
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)RecruitingHIV Prevention | Healthy VolunteerUnited States
-
Prof Mags BeksinskaCompletedHIV Prevention | Pregnancy PreventionSouth Africa
-
Yale UniversityCompletedHIV Prevention | STI PreventionUnited States
-
Centers for Disease Control and PreventionUniversity of Minnesota; The Fenway Institute; AIDS Action Committee of Massachusetts and other collaboratorsCompletedHIV Prevention | STD PreventionUnited States
-
Montefiore Medical CenterNational Institute on Drug Abuse (NIDA)RecruitingHIV Prevention | Injection Drug UseUnited States
Clinical Trials on WERK Supportive Contact
-
University of California, San DiegoNational Institute of Mental Health (NIMH)Completed
-
US Department of Veterans AffairsCompletedPsychotic Disorders | Schizophrenia | Schizoaffective DisorderUnited States
-
VA Office of Research and DevelopmentPortland VA Medical CenterCompletedMild Cognitive ImpairmentUnited States
-
University of California, San DiegoNational Institute of Mental Health (NIMH)RecruitingSchizoaffective Disorder | Schizophenia DisorderUnited States
-
University of California, San DiegoNational Institute of Mental Health (NIMH)CompletedSchizophreniaUnited States
-
Veterans Medical Research FoundationNational Institute of Mental Health (NIMH)CompletedSchizophreniaUnited States
-
Portland VA Medical CenterOregon Health and Science UniversityRecruitingCognitive Dysfunction | Major Depressive Disorder (MDD)United States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedOvarian Carcinoma | Malignant Uterine Neoplasm | Malignant Female Reproductive System Neoplasm | Ovarian Neoplasm | Uterine Neoplasm | Female Reproductive System Neoplasm | Suspicious for MalignancyUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Completed
-
Aller, Thomas A., ODJohnson & Johnson Vision Care, Inc.CompletedMyopia | Esophoria | Fixation Disparity